[ad_1]
Aurobindo Pharma announced today that it has entered into a pact to acquire Apotex's business operations in five European countries, including Poland and Spain, for an amount of $ 74 million. ; euro.
This acquisition fits into the growth and development strategy Aurobindo Pharma said in a statement that the Hyderabad-based pharmaceutical company had signed a definitive agreement to acquire from Apotex International Inc. its commercial operations and certain support infrastructures in five European countries. 19659002] As part of this agreement, Aurobindo would purchase commercial infrastructure including staff, products, marketing authorizations and file licensing fees in Poland, the Czech Republic, the Netherlands (including a Leiden factory), Spain and Belgium. In Poland, Aurobindo will add significant sales based on the established APO brand as well as a dedicated sales force covering
In Poland and the Czech Republic, Aurobindo will become one of the 15 largest generic companies in each country, according to the company.
In the Netherlands, the acquisition of Aurobindo A leading company in terms of volume of OTC transactions, while in Spain, it will strengthen the company's position in the market for generic drugs , she adds.
In Belgium, the deal would allow Aurobindo to enter the retail business. includes a portfolio of more than 200 prescription drugs (Rx) and 88 OTC products and an additional pipeline of more than 20 products expected to be launched over the next two years, Aurobindo said.
The Indian company and Apotex will enter The acquisition announced today is part of the strategy of growth and diversification of our business in Europe. The acquisition of Apotex businesses in these five key countries will allow us to further expand our product offering, including over-the-counter medicines in the Netherlands, and significantly strengthen our position in Europe. from the East, "said Aurobindo. Since 1965 he acquired the business activities of Actavis in seven countries of Western Europe
last year, he acquired the Portuguese company Generis Farmaceutica
The Hyderabad-based company is presently present in nine European countries.
Source link
